Brief: Codexis And Molecular Assemblies Announce Execution Of Commercial License And Enzyme Supply Agreement For Optimized Tdt Enzyme For Enzymatic Dna Synthesis
02/08/2022 22:41
Aug 2 (Reuters) - Codexis Inc CDXS.O :
* CODEXIS AND MOLECULAR ASSEMBLIES ANNOUNCE EXECUTION OF
COMMERCIAL LICENSE AND ENZYME SUPPLY AGREEMENT FOR OPTIMIZED TDT
ENZYME FOR ENZYMATIC DNA SYNTHESIS
* CODEXIS INC - UNDER TERMS OF AGREEMENT, MOLECULAR
ASSEMBLIES HAS
EXCLUSIVELY LICENSED CODEXIS EVOLVED TDT ENZYME FOR COMMERCIAL
USE IN DNA SYNTHESIS
Source text for Eikon: ID:nGNX97h5tN
Further company coverage: CDXS.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Codexis
See all newsCodexis, Inc. reports results for the quarter ended June 30 - Earnings Summary
Codexis Q2 net loss narrows, helped by lower operating expenses
Codexis, Inc. expected to post a loss of 14 cents a share - Earnings Preview
U.S. STOCKS ON THE MOVE-Tenet, SLB, Digital Realty
U.S. STOCKS ON THE MOVE-Booz Allen Hamilton, Sensient, Amkor